{"id":38747,"date":"2025-08-01T08:38:59","date_gmt":"2025-08-01T08:38:59","guid":{"rendered":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/"},"modified":"2025-08-01T08:38:59","modified_gmt":"2025-08-01T08:38:59","slug":"nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques","status":"publish","type":"post","link":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/","title":{"rendered":"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques"},"content":{"rendered":"

Un estudi publicat al New England Journal of Medicine, amb participaci\u00f3 del grup de recerca Vasculitis sist\u00e8miques de l\u2019IDIBAPS, presenta l\u2019Upadacitinib com una nova opci\u00f3 terap\u00e8utica efica\u00e7 i segura per a l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia inflamat\u00f2ria que afecta principalment persones grans i que fins ara comptava amb poques alternatives de tractament.&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"

Un estudi publicat al New England Journal of Medicine, amb participaci\u00f3 del grup de recerca Vasculitis sist\u00e8miques de l\u2019IDIBAPS, presenta l\u2019Upadacitinib com una nova opci\u00f3 terap\u00e8utica efica\u00e7 i segura per a l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia inflamat\u00f2ria que afecta principalment persones grans i que fins ara comptava amb poques alternatives de tractament.&nbsp;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"tipo":[],"class_list":{"0":"post-38747","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-uncategorized"},"acf":[],"yoast_head":"\nNou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques - Recerca en salut<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel\u00b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques - Recerca en salut\" \/>\n<meta property=\"og:description\" content=\"Un estudi publicat al New England Journal of Medicine, amb participaci\u00f3 del grup de recerca Vasculitis sist\u00e8miques de l\u2019IDIBAPS, presenta l\u2019Upadacitinib com una nova opci\u00f3 terap\u00e8utica efica\u00e7 i segura per a l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia inflamat\u00f2ria que afecta principalment persones grans i que fins ara comptava amb poques alternatives de tractament.&nbsp;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel\u00b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\" \/>\n<meta property=\"og:site_name\" content=\"Recerca en salut\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-01T08:38:59+00:00\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\"},\"author\":{\"name\":\"Redacci\u00f3\",\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4\"},\"headline\":\"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques\",\"datePublished\":\"2025-08-01T08:38:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\"},\"wordCount\":83,\"commentCount\":0,\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\",\"url\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\",\"name\":\"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques - Recerca en salut\",\"isPartOf\":{\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website\"},\"datePublished\":\"2025-08-01T08:38:59+00:00\",\"author\":{\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4\"},\"breadcrumb\":{\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website\",\"url\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/\",\"name\":\"Recerca en salut\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4\",\"name\":\"Redacci\u00f3\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3\"},\"url\":\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/author\/npenin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques - Recerca en salut","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel\u00b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/","og_locale":"es_ES","og_type":"article","og_title":"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques - Recerca en salut","og_description":"Un estudi publicat al New England Journal of Medicine, amb participaci\u00f3 del grup de recerca Vasculitis sist\u00e8miques de l\u2019IDIBAPS, presenta l\u2019Upadacitinib com una nova opci\u00f3 terap\u00e8utica efica\u00e7 i segura per a l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia inflamat\u00f2ria que afecta principalment persones grans i que fins ara comptava amb poques alternatives de tractament.&nbsp;","og_url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel\u00b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/","og_site_name":"Recerca en salut","article_published_time":"2025-08-01T08:38:59+00:00","author":"Redacci\u00f3","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Redacci\u00f3"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#article","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/"},"author":{"name":"Redacci\u00f3","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4"},"headline":"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques","datePublished":"2025-08-01T08:38:59+00:00","mainEntityOfPage":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/"},"wordCount":83,"commentCount":0,"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/","name":"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques - Recerca en salut","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website"},"datePublished":"2025-08-01T08:38:59+00:00","author":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4"},"breadcrumb":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2025\/08\/01\/nou-tractament-segur-i-eficac-per-larteritis-de-cel%c2%b7lules-gegants-una-malaltia-amb-poques-opcions-terapeutiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/diarisanitat.cat\/recerca-en-salut\/"},{"@type":"ListItem","position":2,"name":"Nou tractament segur i efica\u00e7 per l\u2019arteritis de c\u00e8l\u00b7lules gegants, una malaltia amb poques opcions terap\u00e8utiques"}]},{"@type":"WebSite","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/","name":"Recerca en salut","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diarisanitat.cat\/recerca-en-salut\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4","name":"Redacci\u00f3","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","caption":"Redacci\u00f3"},"url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/author\/npenin\/"}]}},"_links":{"self":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/38747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/comments?post=38747"}],"version-history":[{"count":0,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/38747\/revisions"}],"wp:attachment":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/media?parent=38747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/categories?post=38747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tags?post=38747"},{"taxonomy":"tipo","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tipo?post=38747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}